Kinga Faulkner

Drug Safety Lead - Roche

Kinga Faulkner, a Drug Safety Lead at a leading pharmaceutical company, specialises in ensuring compliance with pharmacovigilance regulations, managing data quality, and mitigating potential safety risks. As a guest speaker, Kinga shares her recent research results and explores the impact of harmonising PV regulations in the post-COVID-19 era, highlighting critical advancements and challenges in this evolving landscape.

Kinga Faulkner


  • Wednesday - September 11, 2024 - 12:20

    Impact of the Harmonisation of PV Regulations in the Post Covid-19 Pandemic Era.


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now